CD44 and breast carcinoma: Based on our data of flow cytometry, the CD44+/CD24− and ALDH1+ primary breast cancer cells varied from 1.8% to 48% and 0.4% to 23.6% respectively, which was verified by ALDH1 immunohistochemical staining.